
Leading Neuromodulation with Science and Passion
Neuropix, the creator of the NX08 wearable, is a pioneer in neuromodulation, committed to transforming personal healthcare. By combining cutting-edge neuroscience with advanced technology, we develop and clinically validate non-invasive, drug-free, and accessible wearable therapies to address troublesome health conditions.
The award-winning NX08 wearable reflects our commitment to advancing the science of neuromodulation. We're on a mission to support millions facing health challenges in avoiding long-term disability, offering users a drug-free therapy that seamlessly integrates into their routine—empowering them to maintain a better quality of life.
Innovating Neurotech
Neuropix was founded by Dr. Daniel Ko (CEO), whose decade of experience in neuromodulation R&D led him to a clear mission: to develop a smarter, easy-to-use, drug-free wearable. Leveraging extensive clinical and pre-clinical expertise, Neuropix merged cutting-edge neuromodulation technology with real-world personal healthcare needs—resulting in a solution that is safe, effective, and accessible
Dr Daniel Ko
"Our mission at Neuropix is to advance bioelectronic therapies that have stood on decades of scientific and medical research - and to make it more accessible for daily living - so that it can directly benefit users in the comfort of their own home."
NX08 Wearable Neurotech That Is Enhancing Lives
At Neuropix, we bring together expertise across neuroscience, biomedical engineering, and software development—all united by a dedication to delivering state-of-the-art bioelectronics that enhance quality of life. The NX08 wearable is built on rigorous scientific research and designed for home use, empowering individuals to manage health challenges without the side effects often associated with traditional medications.
Partner with us
Advancing innovation in bioelectronics alongside our healthcare and industry partners is an exciting journey. Driven by our shared passion, we combine world-class bioengineering with neuromodulation to address global health challenges. We warmly welcome new partners to join us on this transformative mission toward better healthcare solutions for all.
News and Media Release
Join Our Newsletter
Sign up with your email address to receive the latest information.
Name *Email *Message
Health Indications
afVNS therapy is used to reduce anxiety and stress, address sleep disturbances, and support healthier aging. It is not an acute therapy and may take several weeks to take effect. Designed as a self-applied treatment, it can be used at the user's convenience. For full healthcare indications, please contact the Neuropix team for further information.

Safety Information
afVNS therapy should not be used by pregnant women, persons with active implants (e.g., cochlear implants, vagus nerve stimulators, or pacemakers), cerebral shunts, or on diseased skin. Users with underlying cardiac conditions should consult their medical doctor to determine suitability. For full use instructions and safety information, please refer to the user manuals.

Subscribe to Our Newsletter








